85 related articles for article (PubMed ID: 12960194)
1. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
2. Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.
Terry SY; Vallis KA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1298-305. PubMed ID: 22336201
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.
Vallis KA; Reilly RM; Scollard D; Merante P; Brade A; Velauthapillai S; Caldwell C; Chan I; Freeman M; Lockwood G; Miller NA; Cornelissen B; Petronis J; Sabate K
Am J Nucl Med Mol Imaging; 2014; 4(2):181-92. PubMed ID: 24753984
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting,
Aghevlian S; Cai Z; Hedley D; Winnik MA; Reilly RM
EJNMMI Radiopharm Chem; 2020 Nov; 5(1):22. PubMed ID: 33169241
[TBL] [Abstract][Full Text] [Related]
5. Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
Cornelissen B; Darbar S; Kersemans V; Allen D; Falzone N; Barbeau J; Smart S; Vallis KA
Nucl Med Biol; 2012 Nov; 39(8):1142-51. PubMed ID: 22819196
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Auger Electron-Emitting Radioimmunotherapy with [
Facca VJ; Cai Z; Ku A; Georgiou CJ; Reilly RM
Mol Pharm; 2023 Dec; 20(12):6407-6419. PubMed ID: 37983089
[TBL] [Abstract][Full Text] [Related]
7. 111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.
Cornelissen B; Waller A; Target C; Kersemans V; Smart S; Vallis KA
EJNMMI Res; 2012 Feb; 2():9. PubMed ID: 22348532
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate-derivatized immunoconjugate of the anti-(carcinoembryonic antigen) monoclonal antibody C46: immunohistological reactivity and pharmacokinetic comparison with a randomly derivatized C46 immunoconjugate.
Rosenstraus MJ; Davis WL; Lopes AD; D'Aleo CJ; Gilman SC
Cancer Immunol Immunother; 1990; 32(4):207-13. PubMed ID: 2261596
[TBL] [Abstract][Full Text] [Related]
9. [
Chan CY; Chen Z; Guibbal F; Dias G; Destro G; O'Neill E; Veal M; Lau D; Mosley M; Wilson TC; Gouverneur V; Cornelissen B
J Nucl Med; 2023 Dec; 64(12):1965-1971. PubMed ID: 37770109
[TBL] [Abstract][Full Text] [Related]
10. Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
Cornelissen B; Waller A; Able S; Vallis KA
Mol Cancer Ther; 2013 Nov; 12(11):2472-82. PubMed ID: 23963362
[TBL] [Abstract][Full Text] [Related]
11. Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer.
Mosley M; Knight J; Neesse A; Michl P; Iezzi M; Kersemans V; Cornelissen B
J Nucl Med; 2015 May; 56(5):745-51. PubMed ID: 25840973
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425.
Senekowitsch-Schmidtke R; Steiner K; Haunschild J; Möllenstädt S; Truckenbrodt R
Cancer Immunol Immunother; 1996 Feb; 42(2):108-14. PubMed ID: 8620519
[TBL] [Abstract][Full Text] [Related]
13. EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer.
Song L; Falzone N; Vallis KA
Int J Radiat Biol; 2016 Nov; 92(11):716-723. PubMed ID: 26999580
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene.
Cho JG; Kim MK; Oh EJ; Yoon EJ; Sohn J; Park MK; Park GH
Mol Cells; 2002 Aug; 14(1):93-100. PubMed ID: 12243359
[TBL] [Abstract][Full Text] [Related]
15. Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape.
Reilly RM; Georgiou CJ; Brown MK; Cai Z
EJNMMI Radiopharm Chem; 2024 May; 9(1):37. PubMed ID: 38703297
[TBL] [Abstract][Full Text] [Related]
16. Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift.
Tantawy MN; McIntyre JO; Yull F; Calcutt MW; Koktysh DS; Wilson AJ; Zu Z; Nyman J; Rhoades J; Peterson TE; Colvin D; McCawley LJ; Rook JM; Fingleton B; Crispens MA; Alvarez RD; Gore JC
Cancer Med; 2024 Feb; 13(3):e6812. PubMed ID: 38239047
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of breast tumor growth in mice after treatment with ceramide analog 315.
Ponnapakkam T; Saulsberry T; Hill T; Hill-Odom M; Goyal N; Anbalagan M; Liu J; Foroozesh M
Anticancer Drugs; 2018 Oct; 29(9):898-903. PubMed ID: 30044300
[TBL] [Abstract][Full Text] [Related]
18. Micellar solution of [
Pijeira MSO; Gomes-da-Silva NC; Ricci-Junior E; Alencar LMR; İlem-Özdemir D; Cavalcanti ADS; Machado DE; Perini JA; Santos-Oliveira R
Int J Pharm; 2024 Mar; 652():123765. PubMed ID: 38195032
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancers.
Bhattacharyya S; Patel N; Wei L; Riffle LA; Kalen JD; Hill GC; Jacobs PM; Zinn KR; Rosenthal E
Medchemcomm; 2014 Sep; 5(9):1337-1346. PubMed ID: 25431648
[TBL] [Abstract][Full Text] [Related]
20. Iodine nanoparticle radiotherapy of human breast cancer growing in the brains of athymic mice.
Hainfeld JF; Ridwan SM; Stanishevskiy FY; Smilowitz HM
Sci Rep; 2020 Sep; 10(1):15627. PubMed ID: 32973267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
